Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2025-12-24 @ 10:34 PM
NCT ID: NCT00474435
Eligibility Criteria: Inclusion Criteria: * A smear-positive pulmonary tuberculosis, based on positive smear of at least two sputum samples with Ziehl-Neelsen (ZN) staining. * HIV-infected as documented by positive HIV antibody test. * Subject is at least 18 years of age at the day of the first dosing of study medication. * Subject is able and willing to sign the Informed Consent Form prior to screening evaluations. * CD4 cell count \> 50 copies/mm3. * Karnofsky score \> 40. * Willing and able to regularly attend the Kibung'oto National Tuberculosis Hospital (KNTH) clinic. Exclusion Criteria: * History of sensitivity/idiosyncrasy to the drug or chemically related compounds or excipients, which may be employed in the trial. * Previously treated for HIV infection with antiretroviral agents. * Pregnant or breastfeeding. * Relevant history or current condition that might interfere with drug absorption, distribution, metabolism or excretion. * A history of severe psychiatric disease such as psychosis, schizophrenia, etc. * Inability to understand the nature and extent of the trial and the procedures required. * Abnormal serum transaminases or creatinine, determined as levels being \> 5 times upper limit of normal. * Active hepatobiliary or hepatic disease (Non B Chronic Hepatitis B/C co-infection is allowed). * CD4 cell count \> 350 cells/mm3.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT00474435
Study Brief:
Protocol Section: NCT00474435